Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danirixin plus oseltamivir vs oseltamivir in hospitalized adults with influenza
2016-002512-40Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of danirixin in influenza (2 arms), sponsored by GSK. Primary endpoint: Time to Clinical Response. Started Sep 2016; status: completed.
02
Drugs
danirixin
03
Conditions
influenza
Beyond the preview
Go deeper on 2016-002512-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002512-40.